Tvardi Therapeutics
TVRD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Tvardi Therapeutics(TVRD) predict that the EBIT is -7.051 M (-61.94%), Miss estimate;the EPS is -0.73 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B61.94%
-0.01B61.51%
-0.00B0.43%
EPSMiss expectations
-0.73--
-0.69--
-0.0400--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf